Use of Artificial Digestive Systems to Investigate the Biopharmaceutical Factors Influencing the Survival of Probiotic Yeast During Gastrointestinal Transit in Humans
- 9 November 2011
- journal article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 29 (6), 1444-1453
- https://doi.org/10.1007/s11095-011-0620-5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Effect of a New Probiotic Saccharomyces cerevisiae Strain on Survival of Escherichia coli O157:H7 in a Dynamic Gastrointestinal ModelApplied and Environmental Microbiology, 2011
- Survival of a Lactococcus lactis strain varies with its carbohydrate preference under in vitro conditions simulated gastrointestinal tractInternational Journal of Food Microbiology, 2010
- Development and Validation of a Continuous In Vitro System Reproducing Some Biotic and Abiotic Factors of the Veal Calf IntestineApplied and Environmental Microbiology, 2010
- Bacteria and chocolate: A successful combination for probiotic deliveryInternational Journal of Food Microbiology, 2010
- ProbioticsAmerican Journal of Health-System Pharmacy, 2010
- Probiotic yeasts: Anti-inflammatory potential of various non-pathogenic strains in experimental colitis in miceWorld Journal of Gastroenterology, 2010
- Effects of yeast probiotic formulation on viability, revival and protection against infection withSalmonella entericassp.entericaserovar Typhimurium in miceLetters in Applied Microbiology, 2009
- Effect of starch- and lipid-based encapsulation on the culturability of two Bifidobacterium longum strainsLetters in Applied Microbiology, 2007
- Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional miceJournal of Medical Microbiology, 2007
- Molecular and physiological comparisons betweenSaccharomyces cerevisiaeandSaccharomyces boulardiiCanadian Journal of Microbiology, 2004